157 related articles for article (PubMed ID: 17495412)
21. Fatal hepatotoxicity associated with troglitazone.
Vella A; de Groen PC; Dinneen SF
Ann Intern Med; 1998 Dec; 129(12):1080. PubMed ID: 9867776
[No Abstract] [Full Text] [Related]
22. Late-onset troglitazone-induced hepatic dysfunction.
Bell DS; Ovalle F
Diabetes Care; 2000 Jan; 23(1):128-9. PubMed ID: 10857986
[No Abstract] [Full Text] [Related]
23. On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
Stern MP
Diabetes Care; 1999 May; 22(5):844-5. PubMed ID: 10332692
[No Abstract] [Full Text] [Related]
24. Current topics in drug metabolism and drug toxicity. Preface.
Yokoi T
Drug Metab Pharmacokinet; 2011; 26(1):1-2. PubMed ID: 21378452
[No Abstract] [Full Text] [Related]
25. Rules and laws of drug hepatotoxicity.
Kaplowitz N
Pharmacoepidemiol Drug Saf; 2006 Apr; 15(4):231-3. PubMed ID: 16552791
[No Abstract] [Full Text] [Related]
26. Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings.
Li H; Heller DS; Leevy CB; Zierer KG; Klein KM
J Diabetes Complications; 2000; 14(3):175-7. PubMed ID: 10989325
[TBL] [Abstract][Full Text] [Related]
27. Hepatotoxicity of the thiazolidinediones.
Tolman KG; Chandramouli J
Clin Liver Dis; 2003 May; 7(2):369-79, vi. PubMed ID: 12879989
[TBL] [Abstract][Full Text] [Related]
28. Difference in the Pharmacokinetics and Hepatic Metabolism of Antidiabetic Drugs in Zucker Diabetic Fatty and Sprague-Dawley Rats.
Zhou X; Rougée LR; Bedwell DW; Cramer JW; Mohutsky MA; Calvert NA; Moulton RD; Cassidy KC; Yumibe NP; Adams LA; Ruterbories KJ
Drug Metab Dispos; 2016 Aug; 44(8):1184-92. PubMed ID: 27217490
[TBL] [Abstract][Full Text] [Related]
29. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
30. Evaluation of the pharmacokinetics, biotransformation and hepatic transporter effects of troglitazone in mice with humanized livers.
Schulz-Utermoehl T; Sarda S; Foster JR; Jacobsen M; Kenna JG; Morikawa Y; Salmu J; Gross G; Wilson ID
Xenobiotica; 2012 Jun; 42(6):503-17. PubMed ID: 22201515
[TBL] [Abstract][Full Text] [Related]
31. Successful preparation of metabolite of troglitazone by in-flow electrochemical reaction on coulometric electrode.
Tahara K; Yano Y; Kanagawa K; Abe Y; Yamada J; Iijima S; Mochizuki M; Nishikawa T
Chem Pharm Bull (Tokyo); 2007 Aug; 55(8):1207-12. PubMed ID: 17666846
[TBL] [Abstract][Full Text] [Related]
32. Troglitazone Inhibits Bile Acid Amidation: A Possible Risk Factor for Liver Injury.
Ogimura E; Nakagawa T; Deguchi J; Sekine S; Ito K; Bando K
Toxicol Sci; 2017 Aug; 158(2):347-355. PubMed ID: 28486596
[TBL] [Abstract][Full Text] [Related]
33. The use of hepatotoxic signals to predict the safety of peroxisome proliferator-activated receptor agonists.
Hastings KL
Expert Opin Drug Metab Toxicol; 2006 Aug; 2(4):489-92. PubMed ID: 16859399
[No Abstract] [Full Text] [Related]
34. Substituting for troglitazone (Rezulin).
Med Lett Drugs Ther; 2000 Apr; 42(1076):36. PubMed ID: 10803176
[No Abstract] [Full Text] [Related]
35. Troglitazone and liver function abnormalities: lessons from a prescription event monitoring study and spontaneous reporting.
Biswas P; Wilton LV; Shakir SA
Drug Saf; 2001; 24(2):149-54. PubMed ID: 11235818
[TBL] [Abstract][Full Text] [Related]
36. Troglitazone (Rezulin) and hepatic injury.
Faich GA; Moseley RH
Pharmacoepidemiol Drug Saf; 2001; 10(6):537-47. PubMed ID: 11828837
[TBL] [Abstract][Full Text] [Related]
37. The metabolic effects of troglitazone in patients with diabetes and end-stage renal disease.
Mohideen P; Bornemann M; Sugihara J; Genadio V; Sugihara V; Arakaki R
Endocrine; 2005 Nov; 28(2):181-6. PubMed ID: 16388091
[TBL] [Abstract][Full Text] [Related]
38. Troglitazone hepatotoxicity: are we getting closer to understanding idiosyncratic liver injury?
Jaeschke H
Toxicol Sci; 2007 May; 97(1):1-3. PubMed ID: 17575588
[No Abstract] [Full Text] [Related]
39. Troglitazone. Is it all over?
Wagenaar LJ; Kuck EM; Hoekstra JB
Neth J Med; 1999 Jul; 55(1):4-12. PubMed ID: 10431549
[TBL] [Abstract][Full Text] [Related]
40. Troglitazone.
Spencer CM; Markham A
Drugs; 1997 Jul; 54(1):89-101; discussion 102. PubMed ID: 9211083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
